The export of medicines may be blocked if it leads to a shortage of medicines in the country.
On Saturday, Canada imposed restrictions on mass exports of prescription drugs if it would cause a shortage of these drugs domestically. This measure was introduced in response to a decree of U.S. President Donald Trump, who ordered to reduce the price of prescription drugs, including by importing them from neighboring Canada.
“Some drugs destined for the Canadian market are prohibited to be imported outside of Canada if this sale would cause or exacerbate a shortage of drugs,” Health Minister Patty Hyde said.
“Companies (importing drugs) will now also be required to provide information to assess existing or potential shortages upon request (DHS) within 24 hours if there is a serious… health risk (Canadian consumers),” the Health Minister said in a statement.
The Health Canada Minister’s order came into effect on Friday, just days before the new prescription drug import regulations, which will allow U.S. licensed companies to import prescription drugs manufactured in Canada into the U.S. in bulk.
Neither the White House nor the Department of Health and Human Services responded to the request for comment.
Trump announced the plan during his first debate with President-elect Joe Biden, who also said during his campaign that he would develop a similar plan for importing medicines to try to reduce the cost of prescription drugs for Americans.
“Canada is a small market that accounts for 2% of global drug sales, with 68% of the medicines produced being supplied to the global market. It is necessary to be vigilant in maintaining the national supply of drugs,” – said in a statement by the Ministry of Health of Canada.
Many suppliers of Canadian medicines opposed the Trump plan, saying that it could lead to a shortage of medicines.